Patent examination guidelines : inventive step of a monoclonal antibody

By: Zheng, Tiansong
Publisher: 2021ISBN: 9781838626082Subject(s): Patent examination -- procedure -- China | Patenting of life forms -- Patentability -- China | Patenting of life forms -- trends | Patent applications -- Biotechnology industryGenre/Form: Book chapter Local URL: SNIPER Full Text In: IAM Life Sciences 2021 2021, pp. 7-12
Tags from this library: No tags from this library for this title. Log in to add tags.
    Average rating: 0.0 (0 votes)

SNIPER Book Chapter

In biopharmaceuticals, an antibody patent is one of the most valuable patents in the field -- It is preferable if the antigen to be directed by the claimed antibody is a novel and inventive one. If it is novel and inventive, a monoclonal antibody patent can be defined directly by the antigen and a patent claim with the broadest scope can be granted. If it is not novel and inventive, although an antibody can still be claimed by a hybridoma producing the antibody or amino acid sequences constituting the antibody, it will be unclear whether such a defined antibody can be considered to be inventive enough -- changes to the Patent Examination Guidelines could be considered a first exploratory step in encouraging research and development in the field of new antibody medicaments in China

Creative Commons Attribution 4.0 International (CC BY 4.0)

Item type Current library Call number Status Date due Barcode Item holds
SNIPER IP Australia Library
SNIPER Articles
2021/00675 (Browse shelf (Opens below)) Available 200802885
Total holds: 0

There are no comments on this title.

to post a comment.

Hosted by Prosentient